Stroke recovery research involves distinct biological and clinical targets compared to the study of acute stroke. We know that moving preclinical treatments into the clinical realm has been fraught with notorious difficulties, one very well known area has been, of course the incredible disappointments with neuroprotection. In comparison stroke recovery involves distinct biological principles and a very different time window, it is in fact unlike acute stroke at all!
We spoke to Dr Dale Corbett Proferssor in Cellular and mollecular medicine in the faculty of Medicine at the Univeristy of Ottawa, who was the lead author on the Stroke Rrecovery and Rehabilitation Roundtable paper on Enhancing the alignment of the preclinical and clinical stroke recovery research pipeline.
The music used in this podcast is 'Kool Kats' by Kevin MacLeod